Concepts (63)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| High-Throughput Nucleotide Sequencing | 3 | 2022 | 889 | 1.450 |
Why?
|
| Metagenomics | 3 | 2022 | 116 | 1.420 |
Why?
|
| Orf virus | 1 | 2025 | 5 | 0.900 |
Why?
|
| Ecthyma, Contagious | 1 | 2025 | 6 | 0.900 |
Why?
|
| Soft Tissue Infections | 2 | 2025 | 90 | 0.840 |
Why?
|
| Streptococcus pyogenes | 1 | 2025 | 81 | 0.840 |
Why?
|
| Streptococcal Infections | 1 | 2025 | 254 | 0.720 |
Why?
|
| Communicable Diseases | 1 | 2022 | 155 | 0.640 |
Why?
|
| Thyroiditis, Suppurative | 1 | 2019 | 5 | 0.610 |
Why?
|
| Thyroid Crisis | 1 | 2019 | 6 | 0.610 |
Why?
|
| Candida tropicalis | 1 | 2019 | 17 | 0.600 |
Why?
|
| Candidiasis | 1 | 2019 | 134 | 0.550 |
Why?
|
| Respiratory Syncytial Virus Infections | 1 | 2018 | 396 | 0.420 |
Why?
|
| Texas | 5 | 2025 | 3661 | 0.380 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2019 | 881 | 0.350 |
Why?
|
| Sensitivity and Specificity | 3 | 2025 | 2080 | 0.280 |
Why?
|
| Retrospective Studies | 6 | 2025 | 17653 | 0.260 |
Why?
|
| Adolescent | 8 | 2025 | 20879 | 0.260 |
Why?
|
| Infant | 6 | 2025 | 13295 | 0.230 |
Why?
|
| Child, Preschool | 7 | 2025 | 15029 | 0.230 |
Why?
|
| Goats | 1 | 2025 | 30 | 0.220 |
Why?
|
| Mycoplasma pneumoniae | 1 | 2025 | 14 | 0.220 |
Why?
|
| Pneumonia, Mycoplasma | 1 | 2025 | 16 | 0.220 |
Why?
|
| Sheep | 1 | 2025 | 228 | 0.210 |
Why?
|
| Typhoid Fever | 1 | 2024 | 17 | 0.210 |
Why?
|
| Salmonella typhi | 1 | 2024 | 19 | 0.210 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2025 | 165 | 0.210 |
Why?
|
| Drug Resistance, Bacterial | 2 | 2025 | 398 | 0.200 |
Why?
|
| Severity of Illness Index | 2 | 2025 | 3040 | 0.200 |
Why?
|
| Plasma | 1 | 2022 | 102 | 0.180 |
Why?
|
| Skin | 1 | 2025 | 543 | 0.180 |
Why?
|
| Child | 6 | 2025 | 26237 | 0.170 |
Why?
|
| Bacteria | 1 | 2025 | 521 | 0.170 |
Why?
|
| Humans | 11 | 2025 | 130534 | 0.160 |
Why?
|
| Immunocompromised Host | 1 | 2022 | 313 | 0.150 |
Why?
|
| Anti-Infective Agents | 1 | 2022 | 265 | 0.150 |
Why?
|
| Thyroidectomy | 1 | 2019 | 97 | 0.140 |
Why?
|
| Male | 8 | 2025 | 64598 | 0.140 |
Why?
|
| Hospitals, Community | 1 | 2018 | 51 | 0.140 |
Why?
|
| Symptom Assessment | 1 | 2018 | 109 | 0.140 |
Why?
|
| Radiography, Thoracic | 1 | 2018 | 144 | 0.130 |
Why?
|
| Hospitals | 1 | 2020 | 434 | 0.130 |
Why?
|
| Sepsis | 1 | 2022 | 493 | 0.130 |
Why?
|
| Incidence | 1 | 2025 | 3336 | 0.130 |
Why?
|
| Female | 7 | 2025 | 70563 | 0.110 |
Why?
|
| Length of Stay | 1 | 2018 | 1412 | 0.090 |
Why?
|
| Infant, Newborn | 1 | 2025 | 8606 | 0.090 |
Why?
|
| Clindamycin | 1 | 2011 | 40 | 0.080 |
Why?
|
| Anti-Bacterial Agents | 3 | 2025 | 2580 | 0.080 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2011 | 194 | 0.080 |
Why?
|
| Staphylococcus aureus | 1 | 2011 | 477 | 0.060 |
Why?
|
| Staphylococcal Infections | 1 | 2011 | 561 | 0.060 |
Why?
|
| Bacterial Proteins | 1 | 2011 | 947 | 0.060 |
Why?
|
| Genetic Variation | 1 | 2011 | 1555 | 0.050 |
Why?
|
| Animals | 1 | 2025 | 33739 | 0.050 |
Why?
|
| Treatment Outcome | 1 | 2019 | 12854 | 0.050 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2025 | 525 | 0.050 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2024 | 156 | 0.050 |
Why?
|
| Streptogramin A | 1 | 2011 | 1 | 0.020 |
Why?
|
| Erythromycin | 1 | 2011 | 20 | 0.020 |
Why?
|
| Staphylococcal Skin Infections | 1 | 2011 | 37 | 0.020 |
Why?
|
| Plasmids | 1 | 2011 | 444 | 0.020 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2011 | 849 | 0.020 |
Why?
|